{
    "organizations": [],
    "uuid": "0c4bc84c19e7b6c40ba9d4d1fceb6f39c63b94c0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-intercept-pharmaceuticals-announce/brief-intercept-pharmaceuticals-announces-pricing-of-upsized-250-mln-public-offering-and-concurrent-private-placement-of-common-stock-idUSASC09V1G",
    "ord_in_thread": 0,
    "title": "BRIEF-Intercept Pharmaceuticals Announces Pricing Of Upsized $250 Mln Public Offering And Concurrent Private Placement Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - Intercept Pharmaceuticals Inc:\n* INTERCEPT PHARMACEUTICALS ANNOUNCES PRICING OF UPSIZED $250 MILLION PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT OF COMMON STOCK\n* ‍PRICED UPSIZED PUBLIC OFFERING OF 2.3 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $64.00 PER SHARE​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-05T20:33:00.000+03:00",
    "crawled": "2018-04-06T22:10:41.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "intercept",
        "pharmaceutical",
        "inc",
        "intercept",
        "pharmaceutical",
        "announces",
        "pricing",
        "upsized",
        "million",
        "public",
        "offering",
        "concurrent",
        "private",
        "placement",
        "common",
        "stock",
        "upsized",
        "public",
        "offering",
        "million",
        "share",
        "common",
        "stock",
        "price",
        "public",
        "per",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}